
PHG · NYSE
Koninklijke Philips N.V.
$26.95 -0.17 (-0.63%)
Company overview
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, including magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE
- Market cap
- $26.3B
- Employees
- 67,247
- Headquarters
- Amsterdam
- Website
- philips.com
- CEO
- Roy W. O. Jakobs
- Listed
- March 17, 1980
- P/E
- 26.68
- Dividend yield
- 3.86%
Company financials
- Revenue
- $17.6B
- Gross profit
- $8B
- Operating income
- $1.5B
- EBITDA
- $2.7B
- Net income
- $970M
- EPS
- $1.01
- Total assets
- $27.3B
- Total debt
- $8.1B
- Gross margin
- 45.20%
- Net margin
- 5.50%
- Earnings yield
- 3.75%
No product segmentation.
Showing FY 2025